Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
After finishing at $237.21 in the prior trading day, Humana Inc (NYSE: HUM) closed at $237.49, up 0.12%. In other words, the price has increased by $0.12 from its previous closing price. On the day, 0.91 million shares were traded. HUM stock price reached its highest trading level at $239.7899 during the session, while it also had its lowest trading level at $234.72.
Ratios:
Our goal is to gain a better understanding of HUM by taking a closer look at its different ratios. In the meantime, Its Debt-to-Equity ratio is 0.75 whereas as Long-Term Debt/Eq ratio is at 0.72.
On November 06, 2024, BofA Securities Upgraded its rating to Neutral which previously was Underperform and also upped its target price recommendation from $247 to $308.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 14 ’25 when Rechtin James A. bought 6,530 shares for $229.25 per share. The transaction valued at 1,496,984 led to the insider holds 30,474 shares of the business.
Diamond Susan M bought 10,959 shares of HUM for $2,732,134 on Apr 08 ’25. On Feb 24 ’25, another insider, Huval Timothy S., who serves as the Former Chief Administrative Of of the company, bought 1,247 shares for $258.58 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HUM now has a Market Capitalization of 28663382016 and an Enterprise Value of 21171140608. As of this moment, Humana’s Price-to-Earnings (P/E) ratio for their current fiscal year is 16.79, and their Forward P/E ratio for the next fiscal year is 16.71. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.62. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.24 while its Price-to-Book (P/B) ratio in mrq is 1.61. Its current Enterprise Value per Revenue stands at 0.176 whereas that against EBITDA is 5.167.
Stock Price History:
The Beta on a monthly basis for HUM is 0.45, which has changed by -0.37365824 over the last 52 weeks, in comparison to a change of 0.10500872 over the same period for the S&P500. Over the past 52 weeks, HUM has reached a high of $406.46, while it has fallen to a 52-week low of $212.45. The 50-Day Moving Average of the stock is -1.48%, while the 200-Day Moving Average is calculated to be -10.18%.
Shares Statistics:
The stock has traded on average 1.86M shares per day over the past 3-months and 1399510 shares per day over the last 10 days, according to various share statistics. A total of 120.69M shares are outstanding, with a floating share count of 120.42M. Insiders hold about 0.22% of the company’s shares, while institutions hold 95.30% stake in the company. Shares short for HUM as of 1749772800 were 4254684 with a Short Ratio of 2.29, compared to 1747267200 on 3440131. Therefore, it implies a Short% of Shares Outstanding of 4254684 and a Short% of Float of 3.95.
Dividends & Splits
In the trailing 12 months, HUM’s forward annual dividend rate was 3.54, compared to 3.54 this year. Against a Trailing Annual Dividend Yield of 0.014923485The stock’s 5-year Average Dividend Yield is 0.8. The current Payout Ratio is 35.45% for HUM, which recently paid a dividend on 2025-06-27 with an ex-dividend date of 1750982400. Stock splits for the company last occurred on 1991-08-01 when the company split stock in a 3:2 ratio.
Earnings Estimates
The stock of Humana Inc (HUM) is currently in the spotlight, with 23.0 analysts actively rating and assessing its market standing.The consensus estimate for the next quarter is $2.59, with high estimates of $3.9 and low estimates of $1.58.
Analysts are recommending an EPS of between $16.98 and $16.24 for the fiscal current year, implying an average EPS of $16.36. EPS for the following year is $14.27, with 25.0 analysts recommending between $18.38 and $10.0.
Revenue Estimates
16 analysts predict $31.84B in revenue for the current quarter. It ranges from a high estimate of $32.35B to a low estimate of $31.41B. As of the current estimate, Humana Inc’s year-ago sales were $29.54BFor the next quarter, 16 analysts are estimating revenue of $31.47B. There is a high estimate of $32.08B for the next quarter, whereas the lowest estimate is $30.69B.
A total of 21 analysts have provided revenue estimates for HUM’s current fiscal year. The highest revenue estimate was $128.03B, while the lowest revenue estimate was $124.47B, resulting in an average revenue estimate of $126.6B. In the same quarter a year ago, actual revenue was $117.76BBased on 20 analysts’ estimates, the company’s revenue will be $130.92B in the next fiscal year. The high estimate is $139.68B and the low estimate is $121.01B.
